Biostatistics and Data Science for Health Care Researchers: A Short Course

Tuesday, November 3, 2026, 1:00 PM - Thursday, November 5, 2026, 4:45 PM, Online


The Department of Biostatistics and Health Data Science in the School of Medicine and Richard M. Fairbanks School of Public Health will present a short course in biostatistics and data science designed especially for health care researchers in the health sciences. The program emphasizes basic concepts, clinical utility, interpretation, and translation rather than theoretical mathematics, bridging clinical evidence with advanced computational pipelines, machine learning, and Generative AI applications in modern EHR systems. This course will consist of three sessions. Session I: Foundational Research Design & Basic Biostatistics will cover basic principles, design of medical research studies, the core logic of clinical evidence, hypothesis testing, and comparing basic groups. Session II: Data Architecture, Diagnostics, & Explanatory Modeling will move from data collection to analyzing relationships between variables and evaluating diagnostic tools. Session III: Advanced Analytics, Machine Learning, & AI will handle complex, multi-variable clinical data and evaluate predictive AI models. Registrants may choose to attend any single Session of choice, Sessions I and II, Sessions II and III, or Sessions I, II and III.

1. Recognize common study designs and statistical methods used in medical research.
2. Discuss complex study design and analysis with a statistician.
3. Specify basic concepts of data management.
4. Identify appropriate use of statistical procedures when given a common study design.
5. Implement simple statistical analyses under the guidance of a statistician

This course will meet Tuesday, Wednesday, and Thursday, November 3-5, 2026 from 1-5pm EST.

Target Audience: Anyone interested in healthcare research.

This meeting will be held virtually via Zoom. A Zoom link will be created for each day of the course, and participants will register with Zoom each day to confirm attendance.

Fee
Single Session of Choice - $30

Sessions I and II - $40

Sessions II and III - $40

Sessions I, II, and III - $60

SUGGESTED INSTRUCTIONAL BOOK
Participants who would like to have additional supplementary information are encouraged
to purchase a copy of the book:
Basic and Clinical Biostatistics, 5th edition,
© 2020, by White, ISBN# 978-1-260-46067-4.

The fee includes access to the PowerPoint slides and video recordings of presentations
each day. The instructional book is not provided.

In support of improving patient care, Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
Indiana University School of Medicine designates this live activity for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn 10 credits toward the CME of the American Board of Surgery's Continuous Certification Program. It is the CME activity's provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit. 

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or [email protected]. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.

AMA PRA Category 1 Credits™ (10.00 hours), ABS CC (10.00 hours), Non-Physician Attendance (10.00 hours)

Indiana University School of Medicine (IUSM) policy ensures that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all financial relationships with ineligible companies so that IUSM may identify relevant financial relationships and mitigate any relevant financial relationships prior to the activity. All educational programs sponsored by Indiana University School of Medicine must demonstrate balance, independence, objectivity, and scientific rigor.

*Indiana University School of Medicine (IUSM) and ACCME defines an ineligible company as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

To view any relevant financial relationships with ineligible companies for anyone who was in control of the content of this activity, please click the names below.  All relevant financial relationships have been mitigated in accordance with ACCME and the IUSM Conflict of Interest Policy.

Mitigation of Relevant Financial Relationships

Indiana University School of Medicine, Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.